To further explore the association between genomic alterations of gliclazide‐associated genes and the survival of patients with bladder cancer, the four identified genes (EGF, EGFR, THBS1, and VEGFA) were used to perform a survival analysis as in the study of The Cancer Genome Atlas Research Network 17. This evidence concerns the gene EGFR and urinary bladder cancer.